Keywords: bioscience, alza, strike, deal, ethyol, signed, marketing
US Bioscience and Alza strike deal for Ethyol
Article | 08 January 1996
- US Bioscience and Alza have signed a marketing and distribution agreement for the former's Ethyol (amifostine), a selective cytoprotective agent ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Is failure to adopt business process management putting the pharma industry at risk?
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
